SunTrust Banks, Inc. set a $54.00 target price on LifePoint Health, Inc. (NASDAQ:LPNT) in a research note released on Tuesday. The firm currently has a hold rating on the stock. SunTrust Banks also issued estimates for LifePoint Health’s Q4 2017 earnings at $0.79 EPS, FY2017 earnings at $3.62 EPS, Q1 2018 earnings at $1.01 EPS, Q2 2018 earnings at $0.96 EPS, Q3 2018 earnings at $0.99 EPS, Q4 2018 earnings at $0.98 EPS, FY2018 earnings at $3.94 EPS, Q1 2019 earnings at $1.13 EPS, Q2 2019 earnings at $1.03 EPS, Q3 2019 earnings at $1.05 EPS and FY2019 earnings at $4.22 EPS.
Several other brokerages have also weighed in on LPNT. BMO Capital Markets started coverage on LifePoint Health in a research note on Monday, October 16th. They issued a market perform rating and a $59.00 price target for the company. ValuEngine upgraded LifePoint Health from a hold rating to a buy rating in a research note on Thursday, August 17th. Raymond James Financial, Inc. restated a market perform rating on shares of LifePoint Health in a research note on Monday. Robert W. Baird set a $55.00 price target on LifePoint Health and gave the company a buy rating in a research note on Monday. Finally, BidaskClub lowered LifePoint Health from a hold rating to a sell rating in a research note on Tuesday, August 1st. Three analysts have rated the stock with a sell rating, thirteen have given a hold rating and four have given a buy rating to the stock. LifePoint Health has a consensus rating of Hold and a consensus price target of $60.14.
Shares of LifePoint Health (LPNT) traded down $0.30 during trading on Tuesday, hitting $46.35. The company had a trading volume of 596,749 shares, compared to its average volume of 619,137. The company has a debt-to-equity ratio of 1.24, a quick ratio of 1.65 and a current ratio of 1.85. The stock has a market cap of $1.82 billion, a PE ratio of 11.79, a price-to-earnings-growth ratio of 1.20 and a beta of 0.68.
LifePoint Health (NASDAQ:LPNT) last announced its quarterly earnings results on Friday, October 27th. The company reported $0.80 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.95 by ($0.15). LifePoint Health had a net margin of 2.45% and a return on equity of 7.01%. The business had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.60 billion. During the same quarter in the prior year, the firm earned $0.94 EPS. LifePoint Health’s revenue for the quarter was down .7% on a year-over-year basis. equities research analysts anticipate that LifePoint Health will post 3.65 EPS for the current year.
LifePoint Health announced that its board has initiated a share repurchase plan on Friday, October 27th that authorizes the company to repurchase $200.00 million in shares. This repurchase authorization authorizes the company to purchase shares of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s board of directors believes its shares are undervalued.
Several hedge funds have recently bought and sold shares of the company. Teacher Retirement System of Texas grew its position in shares of LifePoint Health by 0.3% in the second quarter. Teacher Retirement System of Texas now owns 3,211 shares of the company’s stock valued at $216,000 after purchasing an additional 9 shares in the last quarter. US Bancorp DE grew its position in shares of LifePoint Health by 0.8% in the second quarter. US Bancorp DE now owns 1,947 shares of the company’s stock valued at $130,000 after purchasing an additional 16 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its position in shares of LifePoint Health by 1.0% in the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 5,891 shares of the company’s stock valued at $396,000 after purchasing an additional 56 shares in the last quarter. Meeder Asset Management Inc. grew its position in shares of LifePoint Health by 0.6% in the second quarter. Meeder Asset Management Inc. now owns 13,547 shares of the company’s stock valued at $909,000 after purchasing an additional 76 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its position in shares of LifePoint Health by 10.8% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,678 shares of the company’s stock valued at $113,000 after purchasing an additional 164 shares in the last quarter. Institutional investors and hedge funds own 99.53% of the company’s stock.
LifePoint Health Company Profile
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
What are top analysts saying about LifePoint Health Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for LifePoint Health Inc. and related companies.